22
Participants
Start Date
June 27, 2019
Primary Completion Date
May 22, 2023
Study Completion Date
September 25, 2023
Device: EVOS Lumbar Interbody System (EVOS-HA)
All subjects will receive the EVOS Lumbar Interbody System (EVOS-HA) device if according to the investigators opinion they are clinically indicated to have surgery treatment for degenerative disc disease and spondylolisthesis.
Thomas Jefferson University Hospital, Philadelphia
OrthoCarolina Research Institute, Charlotte
Lead Sponsor
Collaborators (1)
Medical Metrics Diagnostics, Inc
INDUSTRY
Invibio Ltd
INDUSTRY